Enzyme vs Solabs: Revenue, Funding & Team Size Compared
Enzyme generates $10.3M in revenue; Solabs generates $10M. Enzyme and Solabs are close to the same size by revenue. The table below compares Enzyme and Solabs on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company |  EnzymeThis company |  Solabs |
|---|---|---|
| Revenue | $10.3M | $10M |
| Valuation | $61.6M | $100M |
| Funding raised | $2M | Not disclosed |
| Customers | 21 | Not disclosed |
| Team size | 33 | 27 |
| Founded | 2018 | 1999 |
| HQ | San Francisco, United States | Brossard, Canada |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
Enzyme at a glance
Enzyme generates $10.3M in revenue with 33 employees, headquartered in San Francisco, United States.
- Revenue
- $10.3M
- Valuation
- $61.6M
- Funding
- $2M
- Customers
- 21
- Team size
- 33
- Founded
- 2018
Automating FDA approval and compliance
Solabs at a glance
Solabs generates $10M in revenue with 27 employees, headquartered in Brossard, Canada.
- Revenue
- $10M
- Valuation
- $100M
- Team size
- 27
- Founded
- 1999
Operator of a software editor platform intended to be used for document management, workflows and training records management. The company's software editor platform uses high integrity and proven technologies together with knowledge-based…
Other Enzyme alternatives
Enzyme competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
Enzyme vs Solabs: frequently asked questions
Is Enzyme or Solabs bigger?
Enzyme is the bigger company by revenue, at $10.3M against $10M for Solabs.
How much revenue does Enzyme make?
Enzyme generates $10.3M in annual revenue with a team of 33.
How much revenue does Solabs make?
Solabs generates $10M in annual revenue with a team of 27.
How much funding has Enzyme raised?
Enzyme has raised $2M in total funding since it was founded in 2018.